Cargando…
Antidepressants and the Risk of Psoriasis Induction: A Case–Control Study
BACKGROUND: Psoriasis (PSO) is a common chronic autoimmune skin disease with a significant psycho-socio-economic burden. Some antidepressants (ADs) such as fluoxetine and bupropion can induce or exacerbate PSO. This study aimed to investigate the correlation between ADs history before PSO onset, and...
Autores principales: | Sadatmadani, Seyedeh-Fatemeh, Siadat, Amir Hossein, Iraji, Fariba, Alsahebfosoul, Fereshteh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012025/ https://www.ncbi.nlm.nih.gov/pubmed/36926437 http://dx.doi.org/10.4103/abr.abr_88_21 |
Ejemplares similares
-
Topical nicotinamide in combination with calcipotriol for the treatment of mild to moderate psoriasis: A double-blind, randomized, comparative study
por: Siadat, Amir Hossein, et al.
Publicado: (2013) -
Efficacy of adding topical simvastatin to topical calcipotriol on improvement of cutaneous plaque psoriasis
por: Iraji, Fariba, et al.
Publicado: (2014) -
Nilotinib-Induced Elephantine Psoriasis In a Patient With Chronic Myeloid Leukemia: A Rare Case Report and Literature Review
por: Sadatmadani, Seyedeh Fatemeh, et al.
Publicado: (2022) -
The efficacy of acyclovir in treatment of the pemphigus vulgaris
por: Iraji, Fariba, et al.
Publicado: (2013) -
Cutaneous leukocytoclastic vasculitis secondary to COVID‐19 infection: A case report
por: Iraji, Fariba, et al.
Publicado: (2020)